1-[(E/Z)-2-(3-methoxy)phenylvinyl]-2-nitrobenzene | 1012321-27-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 1-[(E/Z)-2-(3-methoxy)phenylvinyl]-2-nitrobenzene
• 英文别名: 1-(3-methoxystyryl)-2-nitrobenzene；1-(3-nethoxystyryl)-2-nitrobenzene；1-[2-(3-methoxyphenyl)ethenyl]-2-nitrobenzene
• CAS: 1012321-27-5
• 化学式: C₁₅H₁₃NO₃
• 分子量: 255.273
• InChiKey: XETVEJHJYMRTPB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.77
• 重原子数：
  19.0
• 可旋转键数：
  4.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  52.37
• 氢给体数：
  0.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  1-[(E/Z)-2-(3-methoxy)phenylvinyl]-2-nitrobenzene 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 反应 12.0h， 以0.95 g的产率得到2-[2-(3-甲氧基苯基)乙基]苯胺
  参考文献：
  名称：

  Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents

  摘要：

  Starting from lead compounds 12b and 28b, previously characterized as P-glycoprotein (P-gp) modulating agents, two series of new compounds were investigated. Compounds 14a,b and 15a,b displayed high P-gp modulating activity in the submicromolar range (EC(50) values from 0.25 to 0.80 mu M). Moreover, amino derivatives 23-27 showed EC(50) values ranging from 0.085 to 0.90 mu M. In the pyridyl series, the best result has been obtained for 4-pyridyl derivative 17b (EC(50) = 0.85 mu M). The best P-gp modulating agents 14a,b, 15a,b, and 23-27 also have been studied for determining their breast cancer resistance protein (BCRP) inhibition activity. The results demonstrated that only the amino derivatives 23-27 displayed moderate BCRP inhibition activity.

  DOI：

  10.1021/jm701267q
• 作为产物：
  描述：

  3-甲氧基氯苄 在 18-冠醚-6 、 potassium carbonate 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 10.5h， 生成 1-[(E/Z)-2-(3-methoxy)phenylvinyl]-2-nitrobenzene
  参考文献：
  名称：

  四氯邻苯二甲酰亚胺作为肝脏X受体β（LXRβ）选择性激动剂的开发

  摘要：

  肝X受体（LXR）激动剂是通过诱导ABCA1（ATP结合盒A1）基因表达来治疗动脉粥样硬化的候选药物，该基因表达有助于逆转胆固醇转运（RCT）并促进肝脏和肠道中胆固醇的排出。但是，LXR激动剂也会诱导参与脂肪形成的基因，例如SREBP-1c（固醇调节结合元件蛋白1c）和FAS（脂肪酸合酶），从而引起血浆和肝甘油三酯（TG）水平的不良增加。最近的研究表明，LXRα有助于肝脏中的脂肪生成，选择性LXRβ活化可改善小鼠的RCT。因此，LXRβ选择性激动剂有望在不增加血浆或肝TG水平的情况下改善动脉粥样硬化。但是，两个LXR同工型α/β中的配体结合结构域具有较高的序列同一性，几乎没有LXR配体显示出亚型选择性。在这项研究中，我们确定了四氯邻苯二甲酰亚胺类似物作为LXRβ选择性激动剂。结构发展导致（E）-4,5,6,7-四氯-2-（2-苯乙烯基苯基）异吲哚啉-1,3-二酮（24 a），这在报告基因测

  DOI：

  10.1002/cmdc.201600305

文献信息

• Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators
  作者：Sayaka Nomura、Kaori Endo-Umeda、Atsushi Aoyama、Makoto Makishima、Yuichi Hashimoto、Minoru Ishikawa

  DOI：10.1021/acsmedchemlett.5b00170

  日期：2015.8.13

  Anti-inflammatory effects of liver X receptor (LXR) ligands are thought to be largely due to LXR-mediated transrepression, whereas side effects are caused by activation of LXR-responsive gene expression (transactivation). Therefore, selective LXR modulators that preferentially exhibit transrepression activity should exhibit anti-inflammatory properties with fewer side effects. Here, we synthesized a series of styrylphenylphthalirnide analogues and evaluated their structure activity relationships focusing on LXRs-transactivating-agonistic/antagonistic activities and transrepressional activity. Among the compounds examined, 171 showed potent LXR-transrepressional activity with high selectivity over transactivating activity and did not show characteristic side effects of LXR-transactivating agonists in cells. This representative compound, 171, was confirmed to have LXR-dependent transrepressional activity and to bind directly to LXR beta. Compound 171 should be useful not only as a chemical tool for studying the biological functions of LXRs transrepression but also as a candidate for a safer agent to treat inflammatory diseases.